A Real-World Evaluation of Atezolizumab Plus Platinum-Etoposide Chemotherapy in Patients With Extensive-Stage SCLC in Canada.
- DOI
- 10.1016/j.jtocrr.2021.100249
- Published
- 2021 Dec
- Container
- JTO clinical and research reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jtocrr.2021.100249,
title = {A Real-World Evaluation of Atezolizumab Plus Platinum-Etoposide Chemotherapy in Patients With Extensive-Stage SCLC in Canada.},
author = {Elegbede AA and Gibson AJ and Fung AS and Cheung WY and Dean ML and Bebb DG and Pabani A},
year = {2021},
journal = {JTO clinical and research reports},
doi = {10.1016/j.jtocrr.2021.100249},
url = {https://doi.org/10.1016/j.jtocrr.2021.100249}
}RIS
TY - JOUR TI - A Real-World Evaluation of Atezolizumab Plus Platinum-Etoposide Chemotherapy in Patients With Extensive-Stage SCLC in Canada. AU - Elegbede AA AU - Gibson AJ AU - Fung AS AU - Cheung WY AU - Dean ML AU - Bebb DG AU - Pabani A PY - 2021 JO - JTO clinical and research reports DO - 10.1016/j.jtocrr.2021.100249 UR - https://doi.org/10.1016/j.jtocrr.2021.100249 ER -
APA
AA, E., AJ, G., AS, F., WY, C., ML, D., DG, B., & A, P. (2021). A Real-World Evaluation of Atezolizumab Plus Platinum-Etoposide Chemotherapy in Patients With Extensive-Stage SCLC in Canada.. JTO clinical and research reports. https://doi.org/10.1016/j.jtocrr.2021.100249
Source records
- pubmed · retrieved 2026-09-27T07:48:38.137Z